1887

Abstract

The non-structural 5A (NS5A) protein of hepatitis C virus (HCV) has been the subject of intensive research over the last decade. It is generally accepted that NS5A is a pleiotropic protein with key roles in both viral RNA replication and modulation of the physiology of the host cell. Our understanding of the role of NS5A in the virus life cycle has been hampered by the lack of a robust system for the study of HCV replication, although the recent development of the subgenomic replicon has at least allowed us to begin to dissect the involvement of NS5A in the process of viral RNA replication. Early studies into the effects of NS5A on cell physiology relied on expression of NS5A either alone or in the context of other non-structural proteins; the advent of the replicon system has allowed the extrapolation of these studies to a more physiologically relevant cellular context. Despite recent progress, this field is controversial, and there is much work to be accomplished before we fully understand the many functions of this protein. In this article, the current state of our knowledge of NS5A, discussing in detail its direct involvement in virus replication, together with its role in modulating the cellular environment to favour virus replication and persistence, are reviewed. The effects of NS5A on interferon signalling, and the regulation of cell growth and apoptosis are highlighted, demonstrating that this protein is indeed of critical importance for HCV and is worthy of further investigation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80204-0
2004-09-01
2019-12-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/9/vir852485.html?itemId=/content/journal/jgv/10.1099/vir.0.80204-0&mimeType=html&fmt=ahah

References

  1. Aizaki, H., Saito, S., Ogino, T., Miyajima, N., Harada, T., Matsuura, Y., Miyamura, T. & Kohase, M. ( 2000; ). Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins. J Interferon Cytokine Res 20, 1111–1120.[CrossRef]
    [Google Scholar]
  2. Ali, S., Pellerin, C., Lamarre, D. & Kukolj, G. ( 2004; ). Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line. J Virol 78, 491–501.[CrossRef]
    [Google Scholar]
  3. Anonymous ( 1999; ). Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6, 35–47.[CrossRef]
    [Google Scholar]
  4. Arima, N., Kao, C. Y., Licht, T., Padmanabhan, R., Sasaguri, Y. & Padmanabhan, R. ( 2001; ). Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. J Biol Chem 276, 12675–12684.[CrossRef]
    [Google Scholar]
  5. Asabe, S. I., Tanji, Y., Satoh, S., Kaneko, T., Kimura, K. & Shimotohno, K. ( 1997; ). The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. J Virol 71, 790–796.
    [Google Scholar]
  6. Ban, K. C., Singh, H., Krishnan, R. & Seow, H. F. ( 2003; ). GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma. Cancer Lett 199, 201–208.[CrossRef]
    [Google Scholar]
  7. Blight, K. J., Kolykhalov, A. A. & Rice, C. M. ( 2000; ). Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972–1974.[CrossRef]
    [Google Scholar]
  8. Blindenbacher, A., Duong, F. H., Hunziker, L. & 9 other authors ( 2003; ). Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 124, 1465–1475.[CrossRef]
    [Google Scholar]
  9. Brass, V., Bieck, E., Montserret, R., Wolk, B., Hellings, J. A., Blum, H. E., Penin, F. & Moradpour, D. ( 2002; ). An amino-terminal amphipathic α-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 277, 8130–8139.[CrossRef]
    [Google Scholar]
  10. Briggs, S. D., Scholtz, B., Jacque, J. M., Swingler, S., Stevenson, M. & Smithgall, T. E. ( 2001; ). HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. J Biol Chem 276, 25605–25611.[CrossRef]
    [Google Scholar]
  11. Bukh, J., Pietschmann, T., Lohmann, V. & 7 other authors ( 2002; ). Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A 99, 14416–14421.[CrossRef]
    [Google Scholar]
  12. Burgert, H. G., Ruzsics, Z., Obermeier, S., Hilgendorf, A., Windheim, M. & Elsing, A. ( 2002; ). Subversion of host defense mechanisms by adenoviruses. Curr Top Microbiol Immunol 269, 273–318.
    [Google Scholar]
  13. Cantley, L. C. ( 2002; ). The phosphoinositide 3-kinase pathway. Science 296, 1655–1657.[CrossRef]
    [Google Scholar]
  14. Chang, L. F. & Karin, M. ( 2001; ). Mammalian MAP kinase signalling cascades. Nature 410, 37–40.[CrossRef]
    [Google Scholar]
  15. Chen, W. & Hahn, W. C. ( 2003; ). SV40 early region oncoproteins and human cell transformation. Histol Histopathol 18, 541–550.
    [Google Scholar]
  16. Choi, J., Lee, K. J., Zheng, Y., Yamaga, A. K., Lai, M. M. & Ou, J. H. ( 2004; ). Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39, 81–89.[CrossRef]
    [Google Scholar]
  17. Chung, K. M., Lee, J., Kim, J. E., Song, O. K., Cho, S., Lim, J., Seedorf, M., Hahm, B. & Jang, S. K. ( 2000; ). Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin β3. J Virol 74, 5233–5241.[CrossRef]
    [Google Scholar]
  18. Chung, Y. L., Sheu, M. L. & Yen, S. H. ( 2003; ). Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int J Cancer 107, 65–73.[CrossRef]
    [Google Scholar]
  19. Coffer, P. J., Jin, J. & Woodgett, J. R. ( 1998; ). Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335, 1–13.
    [Google Scholar]
  20. Coito, C., Diamond, D. L., Neddermann, P., Korth, M. J. & Katze, M. G. ( 2004; ). High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylate the hepatitis C virus NS5A protein. J Virol 78, 3502–3513.[CrossRef]
    [Google Scholar]
  21. Cooray, S. ( 2004; ). The pivotal role of phosphatidylinositol 3-kinase–Akt signal transduction in virus survival. J Gen Virol 85, 1065–1076.[CrossRef]
    [Google Scholar]
  22. Cory, S. & Adams, J. M. ( 2002; ). The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2, 647–656.[CrossRef]
    [Google Scholar]
  23. Cui, J., Zhou, X. D., Liu, Y. K., Tang, Z. Y. & Romeih, M. ( 2003; ). Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of β-catenin, T-cell factor-4 and glycogen synthase kinase 3-β genes. J Gastroenterol Hepatol 18, 280–287.[CrossRef]
    [Google Scholar]
  24. Desbois-Mouthon, C., Blivet-Van Eggelpoel, M. J., Beurel, E., Boissan, M., Delelo, R., Cadoret, A. & Capeau, J. ( 2002; ). Dysregulation of glycogen synthase kinase-3β signaling in hepatocellular carcinoma cells. Hepatology 36, 1528–1536.[CrossRef]
    [Google Scholar]
  25. Dimitrova, M., Imbert, I., Kieny, M. P. & Schuster, C. ( 2003; ). Protein-protein interactions between hepatitis C virus nonstructural proteins. J Virol 77, 5401–5414.[CrossRef]
    [Google Scholar]
  26. Edamoto, Y., Hara, A., Biernat, W. & 7 other authors ( 2003; ). Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 106, 334–341.[CrossRef]
    [Google Scholar]
  27. Egger, D., Wolk, B., Gosert, R., Bianchi, L., Blum, H. E., Moradpour, D. & Bienz, K. ( 2002; ). Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 76, 5974–5984.[CrossRef]
    [Google Scholar]
  28. Elazar, M., Cheong, K. H., Liu, P., Greenberg, H. B., Rice, C. M. & Glenn, J. S. ( 2003; ). Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol 77, 6055–6061.[CrossRef]
    [Google Scholar]
  29. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F. & Sato, C. ( 1995; ). Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96, 224–230.[CrossRef]
    [Google Scholar]
  30. Enomoto, N., Sakuma, I., Asahina, Y. & 7 other authors ( 1996; ). Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334, 77–81.[CrossRef]
    [Google Scholar]
  31. Ezelle, H. J., Balachandran, S., Sicheri, F., Polyak, S. J. & Barber, G. N. ( 2001; ). Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A. Virology 281, 124–137.[CrossRef]
    [Google Scholar]
  32. Freeman, A., Hamid, S., Morris, L., Vowler, S., Rushbrook, S., Wight, D. G., Coleman, N. & Alexander, G. J. ( 2003; ). Improved detection of hepatocyte proliferation using antibody to the pre-replication complex: an association with hepatic fibrosis and viral replication in chronic hepatitis C virus infection. J Viral Hepat 10, 345–350.[CrossRef]
    [Google Scholar]
  33. Frese, M., Pietschmann, T., Moradpour, D., Haller, O. & Bartenschlager, R. ( 2001; ). Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82, 723–733.
    [Google Scholar]
  34. Fridman, J. S. & Lowe, S. W. ( 2003; ). Control of apoptosis by p53. Oncogene 22, 9030–9040.[CrossRef]
    [Google Scholar]
  35. Gale, M. J., Jr, Korth, M. J., Tang, N. M., Tan, S. L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R. & Katze, M. G. ( 1997; ). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217–227.[CrossRef]
    [Google Scholar]
  36. Gale, M., Jr, Blakely, C. M., Kwieciszewski, B. & 7 other authors ( 1998; ). Control of PKR protein kinase by hepatitis C virus nonstructural 5a protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18, 5208–5218.
    [Google Scholar]
  37. Gao, L., Aizaki, H., He, J. W. & Lai, M. M. ( 2004; ). Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol 78, 3480–3488.[CrossRef]
    [Google Scholar]
  38. Gaur, U. & Aggarwal, B. B. ( 2003; ). Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66, 1403–1408.[CrossRef]
    [Google Scholar]
  39. Georgopoulou, U., Caravokiri, K. & Mavromara, P. ( 2003; ). Suppression of the ERK1/2 signaling pathway from HCV NS5A protein expressed by herpes simplex recombinant viruses. Arch Virol 148, 237–251.[CrossRef]
    [Google Scholar]
  40. Ghosh, A. K., Steele, R., Meyer, K., Ray, R. & Ray, R. B. ( 1999; ). Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 80, 1179–1183.
    [Google Scholar]
  41. Ghosh, A. K., Majumder, M., Steele, R., Meyer, K., Ray, R. & Ray, R. B. ( 2000a; ). Hepatitis C virus NSSA protein protects against TNF-α mediated apoptotic cell death. Virus Res 67, 173–178.[CrossRef]
    [Google Scholar]
  42. Ghosh, A. K., Majumder, M., Steele, R., Yaciuk, P., Chrivia, J., Ray, R. & Ray, R. B. ( 2000b; ). Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J Biol Chem 275, 7184–7188.[CrossRef]
    [Google Scholar]
  43. Ghosh, A. K., Majumder, M., Steele, R., Ray, R. & Ray, R. B. ( 2003; ). Modulation of interferon expression by hepatitis C virus NS5A protein and human homeodomain protein PTX1. Virology 306, 51–59.[CrossRef]
    [Google Scholar]
  44. Girard, S., Shalhoub, P., Lescure, P., Sabile, A., Misek, D. E., Hanash, S., Brechot, C. & Beretta, L. ( 2002; ). An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295, 272–283.[CrossRef]
    [Google Scholar]
  45. Gong, G. Z., Waris, G., Tanveer, R. & Siddiqui, A. ( 2001; ). Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc Natl Acad Sci U S A 98, 9599–9604.[CrossRef]
    [Google Scholar]
  46. Griffin, S. D. C., Beales, L. P., Clarke, D. S., Worsfold, O., Evans, S. D., Jaeger, J., Harris, M. P. G. & Rowlands, D. J. ( 2003; ). The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 535, 34–38.[CrossRef]
    [Google Scholar]
  47. Guo, J. T., Bichko, V. V. & Seeger, C. ( 2001; ). Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75, 8516–8523.[CrossRef]
    [Google Scholar]
  48. Hanafusa, H., Torii, S., Yasunaga, T. & Nishida, E. ( 2002; ). Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 4, 850–858.[CrossRef]
    [Google Scholar]
  49. Harcourt, J. L. & Offermann, M. K. ( 2001; ). Multiple signaling cascades are differentially involved in gene induction by double stranded RNA in interferon-α-primed cells. Eur J Biochem 268, 1373–1381.[CrossRef]
    [Google Scholar]
  50. Hardy, R. W., Marcotrigiano, J., Blight, K. J., Majors, J. E. & Rice, C. M. ( 2003; ). Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells. J Virol 77, 2029–2037.[CrossRef]
    [Google Scholar]
  51. Harris, M. ( 1996; ). From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef. J Gen Virol 77, 2379–2392.[CrossRef]
    [Google Scholar]
  52. He, Y. P., Tan, S. L., Tareen, S. U., Vijaysri, S., Langland, J. O., Jacobs, B. L. & Katze, M. G. ( 2001; ). Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J Virol 75, 5090–5098.[CrossRef]
    [Google Scholar]
  53. He, Y. P., Nakao, H. H., Tan, S. L., Polyak, P. J., Neddermann, P., Vijaysri, S., Jacobs, B. L. & Katze, M. G. ( 2002; ). Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol 76, 9207–9217.[CrossRef]
    [Google Scholar]
  54. He, Y. P., Yan, W., Coito, C., Li, Y., Gale, M., Jr & Katze, M. G. ( 2003; ). The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins. J Gen Virol 84, 535–543.[CrossRef]
    [Google Scholar]
  55. Heim, M. H., Moradpour, D. & Blum, H. E. ( 1999; ). Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 73, 8469–8475.
    [Google Scholar]
  56. Honda, M., Kaneko, S., Matsushita, E., Kobayashi, K., Abell, G. A. & Lemon, S. M. ( 2000; ). Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 118, 152–162.[CrossRef]
    [Google Scholar]
  57. Houshmand, H. & Bergqvist, A. ( 2003; ). Interaction of hepatitis C virus NS5A with La protein revealed by T7 phage display. Biochem Biophys Res Commun 309, 695–701.[CrossRef]
    [Google Scholar]
  58. Ide, Y., Zhang, L. W., Chen, M., Inchauspe, G., Bahl, C., Sasaguri, Y. & Padmanabhan, R. ( 1996; ). Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182, 203–211.[CrossRef]
    [Google Scholar]
  59. Ide, Y., Tanimoto, A., Sasaguri, Y. & Padmanabhan, R. ( 1997; ). Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-α catalytic subunit. Gene 201, 151–158.[CrossRef]
    [Google Scholar]
  60. Ikeda, M., Yi, M. K., Li, K. & Lemon, S. M. ( 2002; ). Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76, 2997–3006.[CrossRef]
    [Google Scholar]
  61. Kaneko, T., Tanji, Y., Satoh, S., Hijikata, M., Asabe, S., Kumura, K. & Shimotohno, K. ( 1994; ). Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 205, 320–326.[CrossRef]
    [Google Scholar]
  62. Katze, M. G., Kwieciszewski, B., Goodlett, D. R., Blakely, C. M., Neddermann, P., Tan, S. L. & Aebersold, R. ( 2000; ). Ser(2194) is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A. Virology 278, 501–513.[CrossRef]
    [Google Scholar]
  63. Khabar, K. S., Al-Zoghaibi, F., Al-Ahdal, M. N. & 8 other authors ( 1997; ). The α chemokine, interleukin 8, inhibits the antiviral action of interferon α. J Exp Med 186, 1077–1085.[CrossRef]
    [Google Scholar]
  64. Kim, J., Lee, D. & Choe, J. ( 1999; ). Hepatitis C virus NS5A protein is phosphorylated by casein kinase II. Biochem Biophys Res Commun 257, 777–781.[CrossRef]
    [Google Scholar]
  65. Klein, N. P. & Schneider, R. J. ( 1997; ). Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol 17, 6427–6436.
    [Google Scholar]
  66. Koch, J. O. & Bartenschlager, R. ( 1999; ). Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B. J Virol 73, 7138–7146.
    [Google Scholar]
  67. Korkaya, H., Jameel, S., Gupta, D. & 9 other authors ( 2001; ). The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem 276, 42389–42400.[CrossRef]
    [Google Scholar]
  68. Krieger, N., Lohmann, V. & Bartenschlager, R. ( 2001; ). Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75, 4614–4624.[CrossRef]
    [Google Scholar]
  69. Kucharczak, J., Simmons, M. J., Fan, Y. & Gelinas, C. ( 2003; ). To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22, 8961–8982.[CrossRef]
    [Google Scholar]
  70. Lan, K. H., Sheu, M. L., Hwang, S. J. & 8 other authors ( 2002; ). HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21, 4801–4811.[CrossRef]
    [Google Scholar]
  71. Lanford, R. E., Guerra, B., Lee, H., Averett, D. R., Pfeiffer, B., Chavez, D., Notvall, L. & Bigger, C. ( 2003; ). Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(I)•poly(C), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J Virol 77, 1092–1104.[CrossRef]
    [Google Scholar]
  72. Liu, Q. Y., Bhat, R. A., Prince, A. M. & Zhang, P. ( 1999; ). The hepatitis C virus NS2 protein generated by NS2-3 autocleavage is required for NS5A phosphorylation. Biochem Biophys Res Commun 254, 572–577.[CrossRef]
    [Google Scholar]
  73. Liu, Z. G., Hsu, H., Goeddel, D. V. & Karin, M. ( 1996; ). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565–576.[CrossRef]
    [Google Scholar]
  74. Lohmann, V., Korner, F., Koch, J. O., Herian, U., Theilmann, L. & Bartenschlager, R. ( 1999; ). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110–113.[CrossRef]
    [Google Scholar]
  75. Lohmann, V., Korner, F., Dobierzewska, A. & Bartenschlager, R. ( 2001; ). Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75, 1437–1449.[CrossRef]
    [Google Scholar]
  76. Macdonald, A., Crowder, K., Street, A., McCormick, C., Saksela, K. & Harris, M. ( 2003; ). The hepatitis C virus non-structural 5A protein inhibits activating protein-1 function by perturbing Ras-ERK pathway signaling. J Biol Chem 278, 17775–17784.[CrossRef]
    [Google Scholar]
  77. Macdonald, A., Crowder, K., Street, A., McCormick, C. & Harris, M. ( 2004; ). The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 85, 721–729.[CrossRef]
    [Google Scholar]
  78. Majumder, M., Ghosh, A. K., Steele, R., Ray, R. & Ray, R. B. ( 2001; ). Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75, 1401–1407.[CrossRef]
    [Google Scholar]
  79. Majumder, M., Ghosh, A. K., Steele, R., Zhou, X. Y., Phillips, N. J., Ray, R. & Ray, R. B. ( 2002; ). Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology 294, 94–105.[CrossRef]
    [Google Scholar]
  80. McCormick, C. J., Challinor, L., Macdonald, A., Rowlands, D. J. & Harris, M. ( 2004; ). Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system. J Gen Virol 85, 429–439.[CrossRef]
    [Google Scholar]
  81. Mercer, D. F., Schiller, D. E., Elliott, J. F. & 9 other authors ( 2001; ). Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7, 927–933.[CrossRef]
    [Google Scholar]
  82. Michael, D. & Oren, M. ( 2003; ). The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13, 49–58.[CrossRef]
    [Google Scholar]
  83. Miyasaka, Y., Enomoto, N., Kurosaki, M. & 9 other authors ( 2003; ). Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factor-α-mediated apoptosis in Huh7 cells. J Infect Dis 188, 1537–1544.[CrossRef]
    [Google Scholar]
  84. Mottola, G., Cardinali, G., Ceccacci, A., Trozzi, C., Bartholomew, L., Torrisi, M. R., Pedrazzini, E., Bonatti, S. & Migliaccio, G. ( 2002; ). Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 293, 31–43.[CrossRef]
    [Google Scholar]
  85. Munger, K. & Howley, P. M. ( 2002; ). Human papillomavirus immortalization and transformation functions. Virus Res 89, 213–228.[CrossRef]
    [Google Scholar]
  86. Murakami, S. ( 2001; ). Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 36, 651–660.[CrossRef]
    [Google Scholar]
  87. Neddermann, P., Clementi, A. & De Francesco, R. ( 1999; ). Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein. J Virol 73, 9984–9991.
    [Google Scholar]
  88. Noguchi, T., Satoh, S., Noshi, T., Hatada, E., Fukuda, R., Kawai, A., Ikeda, S., Hijikata, M. & Shimotohno, K. ( 2001; ). Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells. Microbiol Immunol 45, 829–840.[CrossRef]
    [Google Scholar]
  89. Nousbaum, J. B., Polyak, S. J., Ray, S. C., Sullivan, D. G., Larson, A. M., Carithers, R. L., Jr & Gretch, D. R. ( 2000; ). Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. J Virol 74, 9028–9038.[CrossRef]
    [Google Scholar]
  90. Park, K. J., Choi, S. H., Lee, S. Y., Hwang, S. B. & Lai, M. M. C. ( 2002; ). Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor α-stimulated nuclear factor κB activation. J Biol Chem 277, 13122–13128.[CrossRef]
    [Google Scholar]
  91. Park, K. J., Choi, S. H., Choi, D. H., Park, J. M., Yie, S. W., Lee, S. Y. & Hwang, S. B. ( 2003; ). Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2. J Biol Chem 278, 30711–30718.[CrossRef]
    [Google Scholar]
  92. Paterson, M., Laxton, C. D., Thomas, H. C., Ackrill, A. M. & Foster, G. R. ( 1999; ). Hepatitis C virus NS5A protein inhibits inteferon antiviral activity, but the effects do not correlate with clinical response. Gastroenterology 117, 1187–1197.[CrossRef]
    [Google Scholar]
  93. Pflugheber, J., Fredericksen, B., Sumpter, R., Jr, Wang, C. F., Ware, F., Sodora, D. L. & Gale, M., Jr ( 2002; ). Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc Natl Acad Sci U S A 99, 4650–4655.[CrossRef]
    [Google Scholar]
  94. Pietschmann, T., Lohmann, V., Rutter, G., Kurpanek, K. & Bartenschlager, R. ( 2001; ). Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 75, 1252–1264.[CrossRef]
    [Google Scholar]
  95. Podevin, P., Sabile, A., Gajardo, R., Delhem, N., Abadie, A., Lozach, P. Y., Beretta, L. & Brechot, C. ( 2001; ). Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner. Hepatology 33, 1503–1511.[CrossRef]
    [Google Scholar]
  96. Polyak, S. J., Paschal, D. M., McArdle, S., Gale, M. J., Jr, Moradpour, D. & Gretch, D. R. ( 1999; ). Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 29, 1262–1271.[CrossRef]
    [Google Scholar]
  97. Polyak, S. J., Khabar, K. S., Paschal, D. M., Ezelle, H. J., Duverlie, G., Barber, G. N., Levy, D. E., Mukaida, N. & Gretch, D. R. ( 2001a; ). Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 75, 6095–6106.[CrossRef]
    [Google Scholar]
  98. Polyak, S. J., Khabar, K. S., Rezeiq, M. & Gretch, D. R. ( 2001b; ). Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 75, 6209–6211.[CrossRef]
    [Google Scholar]
  99. Poynard, T., Yuen, M. F., Ratziu, V. & Lai, C. L. ( 2003; ). Viral hepatitis C. Lancet 362, 2095–2100.[CrossRef]
    [Google Scholar]
  100. Prange, W., Breuhahn, K., Fischer, F., Zilkens, C., Pietsch, T., Petmecky, K., Eilers, R., Dienes, H. P. & Schirmacher, P. ( 2003; ). β-Catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol 201, 250–259.[CrossRef]
    [Google Scholar]
  101. Qadri, I., Iwahashi, M. & Simon, F. ( 2002; ). Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 1592, 193–204.[CrossRef]
    [Google Scholar]
  102. Qadri, I., Iwahashi, M., Capasso, J. M., Hopken, M. W., Flores, S., Schaack, J. & Simon, F. R. ( 2004; ). Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J 378, 919–928.[CrossRef]
    [Google Scholar]
  103. Qin, W., Yamashita, T., Shirota, Y., Lin, Y., Wei, W. & Murakami, S. ( 2001; ). Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase. Hepatology 33, 728–737.[CrossRef]
    [Google Scholar]
  104. Reed, K. E. & Rice, C. M. ( 1999; ). Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A protein as serine 2321. J Biol Chem 274, 28011–28018.[CrossRef]
    [Google Scholar]
  105. Reed, K. E., Xu, J. & Rice, C. M. ( 1997; ). Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J Virol 71, 7187–7197.
    [Google Scholar]
  106. Renkema, G. H. & Saksela, K. ( 2000; ). Interactions of HIV-1 Nef with cellular signal transducing proteins. Front Biosci 5, D268–283.[CrossRef]
    [Google Scholar]
  107. Saragovi, H. U., Rebai, N., Di Guglielmo, G. M., MacLeod, R., Sheng, J. S., Rubin, D. H. & Greene, M. I. ( 1999; ). A G1 cell cycle arrest induced by ligands of the reovirus type 3 receptor is secondary to inactivation of p21ras and mitogen-activated protein kinase. DNA Cell Biol 18, 763–770.[CrossRef]
    [Google Scholar]
  108. Satoh, S., Hirota, M., Noguchi, T., Hijikata, M., Handa, H. & Shimotohno, K. ( 2000; ). Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. Virology 270, 476–487.[CrossRef]
    [Google Scholar]
  109. Shang, X. Z., Zhu, H., Lin, K., Tu, Z., Chen, J., Nelson, D. R. & Liu, C. ( 2004; ). Stabilized β-catenin promotes hepatocyte proliferation and inhibits TNFα-induced apoptosis. Lab Invest 84, 332–341.[CrossRef]
    [Google Scholar]
  110. Shi, S. T., Polyak, S. J., Tu, H., Taylor, D. R., Gretch, D. R. & Lai, M. M. C. ( 2002; ). Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292, 198–210.[CrossRef]
    [Google Scholar]
  111. Shi, S. T., Lee, K. J., Aizaki, H., Hwang, S. B. & Lai, M. M. ( 2003; ). Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol 77, 4160–4168.[CrossRef]
    [Google Scholar]
  112. Shimakami, T., Hijikata, M., Luo, H., Ma, Y. Y., Kaneko, S., Shimotohno, K. & Murakami, S. ( 2004; ). Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon. J Virol 78, 2738–2748.[CrossRef]
    [Google Scholar]
  113. Shirota, Y., Luo, H., Qin, W. P., Kaneko, S., Yamashita, T., Kobayashi, K. & Murakami, S. ( 2002; ). Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J Biol Chem 277, 11149–11155.[CrossRef]
    [Google Scholar]
  114. Shuai, K. ( 2003; ). Serine phosphorylation: arming Stat1 against infection. Immunity 19, 771–772.[CrossRef]
    [Google Scholar]
  115. Simon, A. R., Rai, U., Fanburg, B. L. & Cochran, B. H. ( 1998; ). Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 275, C1640–1652.
    [Google Scholar]
  116. Song, J. H., So, E. Y. & Lee, C. E. ( 2002; ). Increased serine phosphorylation and activation of STAT1 by oncogenic Ras transfection. Mol Cells 13, 322–326.
    [Google Scholar]
  117. Street, A., Macdonald, A., Crowder, K. & Harris, M. ( 2004; ). The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem 279, 12232–12241.[CrossRef]
    [Google Scholar]
  118. Tai, D. I., Tsai, S. L., Chen, Y. M. & 8 other authors ( 2000; ). Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31, 656–664.[CrossRef]
    [Google Scholar]
  119. Talarmin, H., Rescan, C., Cariou, S., Glaise, D., Zanninelli, G., Bilodeau, M., Loyer, P., Guguen-Guillouzo, C. & Baffet, G. ( 1999; ). The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes. Mol Cell Biol 19, 6003–6011.
    [Google Scholar]
  120. Tan, S. L. & Katze, M. G. ( 2001; ). How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 284, 1–12.[CrossRef]
    [Google Scholar]
  121. Tan, S. L., Nakao, H., He, Y. P., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J. & Katze, M. G. ( 1999; ). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96, 5533–5538.[CrossRef]
    [Google Scholar]
  122. Tang, E. D., Nunez, G., Barr, F. G. & Guan, K. L. ( 1999; ). Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274, 16741–16746.[CrossRef]
    [Google Scholar]
  123. Tanji, Y., Kaneko, T., Satoh, S. & Shimotohno, K. ( 1995; ). Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 69, 3980–3986.
    [Google Scholar]
  124. Tari, A. M. & Lopez-Berestein, G. ( 2001; ). GRB2: a pivotal protein in signal transduction. Semin Oncol 28, 142–147.[CrossRef]
    [Google Scholar]
  125. Tu, H., Gao, L., Shi, S. T. & 7 other authors ( 1999; ). Hepatitis C virus RNA polymerase and NS5A complex with a SNARE- like protein. Virology 263, 30–41.[CrossRef]
    [Google Scholar]
  126. Wang, C. F., Pflugheber, J., Sumpter, R., Jr, Sodora, D. L., Hui, D., Sen, G. C. & Gale, M., Jr ( 2003; ). Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 77, 3898–3912.[CrossRef]
    [Google Scholar]
  127. Wang, X., Flynn, A., Waskiewicz, A. J., Webb, B. L., Vries, R. G., Baines, I. A., Cooper, J. A. & Proud, C. G. ( 1998; ). The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem 273, 9373–9377.[CrossRef]
    [Google Scholar]
  128. Waris, G., Livolsi, A., Imbert, V., Peyron, J. F. & Siddiqui, A. ( 2003; ). Hepatitis C virus NS5A and subgenomic replicon activate NF-κB via tyrosine phosphorylation of IκBα and its degradation by calpain protease. J Biol Chem 278, 40778–40787.[CrossRef]
    [Google Scholar]
  129. Waris, G., Sarker, S. & Siddiqui, A. ( 2004; ). Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA 10, 321–329.[CrossRef]
    [Google Scholar]
  130. Williams, B. R. ( 2001; ). Signal integration via PKR. Sci STKE 89, RE2.
    [Google Scholar]
  131. Xu, Z., Choi, J., Lu, W. & Ou, J. H. ( 2003; ). Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum. J Virol 77, 1578–1583.[CrossRef]
    [Google Scholar]
  132. Yoshikawa, H., Matsubara, K., Qian, G. S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C. & Herman, J. G. ( 2001; ). SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28, 29–35.
    [Google Scholar]
  133. Zech, B., Kurtenbach, A., Krieger, N. & 10 other authors ( 2003; ). Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein. J Gen Virol 84, 555–560.[CrossRef]
    [Google Scholar]
  134. Zhu, H. & Liu, C. ( 2003; ). Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J Virol 77, 5493–5498.[CrossRef]
    [Google Scholar]
  135. Zhu, Q., Guo, J. T. & Seeger, C. ( 2003; ). Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 77, 9204–9210.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80204-0
Loading
/content/journal/jgv/10.1099/vir.0.80204-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error